Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.
Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology. The company develops a protein engineering platform designed for multispecific therapies.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 14, 2021 | Series A | $50M | 2 |
Versant Ventures
Samsara BioCapital
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
Yes | Series A |
Samsara BioCapital
|
Yes | Series A |